Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07049653 · ClinicalTrials.gov registry record

Anifrolumab Pregnancy Study

A clinical trial, sponsored by AstraZeneca.

Recruiting
Registry status
500
Enrollment target

NCT07049653 is a clinical trial that is actively recruiting participants, run by AstraZeneca. The registered enrollment target is 500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07049653 is actively recruiting participants, sponsored by AstraZeneca.

RECRUITING
Registry status
500 participants
Enrollment target

Study Summary

This is a non-interventional multi-database post-authorisation study to assess pregnancy-related safety data from women with SLE exposed to Anifrolumab.

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2026-06-04
Est. Completion 2030-12-10

Sponsor

AstraZeneca

1,285 total trials

What the Registry Record Tells You About NCT07049653

The ClinicalTrials.gov registry entry for NCT07049653 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT07049653 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07049653 about?

NCT07049653 is a clinical study titled "Anifrolumab Pregnancy Study". This is a non-interventional multi-database post-authorisation study to assess pregnancy-related safety data from women with SLE exposed to Anifrolumab.

What is the current status of trial NCT07049653?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2026-06-04. Estimated completion is 2030-12-10.

Who is sponsoring clinical trial NCT07049653?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.